Representation of Women in Oncology Faculty Increased Over Time While Underrepresented Racial/Ethnic Groups Remain Low

Article

In radiation oncology and medical oncology, representation of female faculty has increased from 1970 to 2019, and representation of individuals from historically underrepresented racial and ethnic groups in medicine remains low.

Representation of female academic faculty members within radiation oncology and medical oncology departments has increased over time, although representation of racial and ethnic groups that have been historically underrepresented in medicine (URM) continue to remain low, according to results from a cross-sectional analysis published in JAMA Oncology.

Using data from the Association of American Medical Colleges (AAMC) to assess the full-time faculty roster from 1970 to 2019, investigators reported that in 1970, the radiation oncology department had a total of 119 total faculty member, 8.4% of whom women and 1.7% URM. Additionally, the medical oncology department had 87 total faculty members, 12.6% of whom were women and 8.0% were URM. In 2019, of 2115 total faculty in the radiation oncology department, 29.1% were women and 5.1% were URM. In the medical oncology department, there were a total of 819 faculty members, with 38.1% and 5.7% being women and URM, respectively.

Compared with non-URM women, the population of whom increased per decade by 0.4% (95% CI, 0.25%-0.80%) in radiation oncology and 0.7% (95% CI, 0.47%-0.87%) in medical oncology (P <.001). Notably, representation of URM women significantly increased by 0.1% (95% CI, 0.005%-0.110%; P <.001) per decade in radiation oncology, with a non-significant increase medical oncology by 0.1% (95% CI, −0.03% to 0.16%; P = .06).

“As academic departments bear primary responsibility for recruiting and educating our future oncology workforce, it is critical that academic faculty are inclusive of individuals who reflect the US population,” the investigators wrote. “Overall, our results indicate that, despite marginal improvements, more progress is needed to recruit and retain a diverse workforce in both radiation oncology and medical oncology, as the current academic workforce still does not reflect the diversity of the general US cancer population nor of the medical school population, particularly regarding URM status.”

Per AAMC definitions, the URM group included Black, Hispanic, and Indigenous individuals. Long-term trends over 5 decades of faculty proportions focused on sex, URM status, and faculty rank. Since yearly changes in faculty were small, the research focuses on change by decade.

When examining diversity by faculty rank, findings indicated that the proportion of women among faculty in radiation and medical oncology departments increased more than the proportion of URM individuals in different ranks, although investigators noted a higher proportion of women faculty members who had lower academic rank than men.

Looking at radiation oncology residency applications (30%), residents (30%), and faculty (29%) from 2019, women had less representation than medical oncology fellowship applicants (46%), fellows (48%), and faculty (38%). Across all clinical departments in 2019, department chairs had the lowest representation of women (17%).

For URM individuals, the proportion of medical school graduates was lower (11%), as was the proportion of radiation oncology residency applicants (13%) and medical oncology fellowship applicants (10%). URM representation among radiation oncology (5%) and medical oncology faculty (5%) was lower than URM representation across all clinical department chairs (9%).

“A key step is to further understand the barriers and shortcomings of current approaches to recruitment and retainment of individuals who are underrepresented in the academic oncology workforce to inform future efforts, along with deliberate investment into career development and advancement of these traditionally marginalized groups,” the investigators concluded.

Reference

Kamran SC, Niemierko A, Deville C Jr, Vapiwala N. Diversity trends by sex and underrepresented in medicine status among US radiation and medical oncology faculty over 5 decades. JAMA Oncol. Published online December 9, 2021. doi:10.1001/jamaoncol.2021.6011

Recent Videos
Geraldine O’Sullivan Coyne, MD, MRCPI, PhD, described the excitement of seeing novel molecules like antibody drug conjugates become more prominent.
Ronald Bleday, MD, credits a chronic pain clinic for consulting patients who may be at a greater risk for prolonged opioid use following surgery.
Ronald Bleday, MD, stated that before standardizing a stepwise approach to treating surgical pain, providers might have overtreated patients with opioids.
Conducting trials safely within a community setting lies at the heart of a successful collaboration between Northwell Health and START.
The expertise of START's network may streamline the availability of clinical trial enrollment and novel treatment options among patients with cancer.
A new START center in New York may give patients with advanced malignancies an opportunity to access novel therapies in the community setting.
START is the largest early phase oncology network in the community-based setting, according to Geraldine O’Sullivan Coyne, MD, MRCPI, PhD.
Related Content